Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Zimmerman

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Blood|March 1, 1996
Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancerS F Williams, W J Lee, J G Bender, et al.
Bone Marrow Transplantation|September 12, 2007
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantationD A Pollyea, A S Artz, W Stock, et al.
The American Journal of Pathology|October 9, 1999
Widespread alterations of alpha-synuclein in multiple system atrophyD W Dickson, W Liu, J Hardy, et al.
Dalton Transactions (Cambridge, England : 2003)|May 24, 2018
DNA interactions of non-chelating tinidazole-based coordination compounds and their structural, redox and cytotoxic propertiesRodrigo Castro-Ramírez, Naytzé Ortiz-Pastrana, Ana B Caballero, et al.
HLA|February 13, 2026
Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown SignificanceShahram Arsang-Jang, Ben Massat, Gokul Pareek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndromeKoen van Besien, A Artz, S Smith, et al.
European Journal of Human Genetics : EJHG|April 13, 2019
Variants in DOCK3 cause developmental delay and hypotoniaKimberly Wiltrout, Alejandro Ferrer, Ingrid van de Laar, et al.
American Journal of Ophthalmology|September 23, 1998
Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study GroupC B Camras, M B Wax, R Ritch, et al.
Pediatric Nephrology (Berlin, Germany)|April 26, 2022
Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group studyYifan Zhang, Talia Gutman, Allison Tong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)Sylvia Adams, Megan Othus, Sandip Pravin Patel, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Blood|March 1, 1996
Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancerS F Williams, W J Lee, J G Bender, et al.
Bone Marrow Transplantation|September 12, 2007
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantationD A Pollyea, A S Artz, W Stock, et al.
The American Journal of Pathology|October 9, 1999
Widespread alterations of alpha-synuclein in multiple system atrophyD W Dickson, W Liu, J Hardy, et al.
Dalton Transactions (Cambridge, England : 2003)|May 24, 2018
DNA interactions of non-chelating tinidazole-based coordination compounds and their structural, redox and cytotoxic propertiesRodrigo Castro-Ramírez, Naytzé Ortiz-Pastrana, Ana B Caballero, et al.
HLA|February 13, 2026
Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown SignificanceShahram Arsang-Jang, Ben Massat, Gokul Pareek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndromeKoen van Besien, A Artz, S Smith, et al.
European Journal of Human Genetics : EJHG|April 13, 2019
Variants in DOCK3 cause developmental delay and hypotoniaKimberly Wiltrout, Alejandro Ferrer, Ingrid van de Laar, et al.
American Journal of Ophthalmology|September 23, 1998
Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study GroupC B Camras, M B Wax, R Ritch, et al.
Pediatric Nephrology (Berlin, Germany)|April 26, 2022
Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group studyYifan Zhang, Talia Gutman, Allison Tong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)Sylvia Adams, Megan Othus, Sandip Pravin Patel, et al.
Pageof 10